Key result
Cardiac implantable electronic device implantation was associated with upper extremity dysfunctions, primarily pain and limited shoulder range of motion, in a systematic review of 696 participants.
Why the study?
Upper extremity dysfunction is a complication of cardiac implantable electronic device implantation that affects activities of daily living, prompting a review of prevailing evidence.
Systematic Review (n=696)
Upper extremity dysfunction, particularly pain and limited shoulder range of motion, is a common but overlooked complication of CIED implantation that can persist long-term and negatively impact quality of life.
Background/Aims The prevalence of cardiac implantable electronic devices has risen considerably during recent years. This has revolutionised the treatment of cardiac arrhythmias, which in turn reduced the incidence of sudden cardiac death. There are several complications associated with cardiac implantable electronic device implantation. Upper extremity dysfunction is one of the complications associated with this procedure and it should be addressed, since it can affect activities of daily living. This systematic review analysed the prevailing evidence pertaining to the common upper extremity dysfunctions associated with receiving a cardiac implantable electronic device. Methods A comprehensive literature search was conducted using PubMed, Cochrane Central Register of Controlled Trials, EMBASE (through Cochrane) and Google Scholar for original research published in the English language. The Rayyan QCRI web application was used for study selection and the decision-making process. PRISMA guidelines were used to conduct and report this review. The methodological quality of the included studies was appraised using the Newcastle–Ottawa Scale and Joanna Briggs Institute critical appraisal tool for analytic cross-sectional studies and case reports. Results This systematic review included eight studies with a total of 696 participants. The most common upper extremity dysfunctions associated with receiving a cardiac implantable electronic device were pain and limitation of shoulder range of motion. Limitation of range of motion could be persisted even in the long term after having a cardiac implantable electronic device implanted. Conclusions Contributing factors of upper extremity dysfunctions included size of the device, pectoral site of implantation and upper extremity immobilisation practices. Upper extremity dysfunction is an overlooked complication, as it received a relatively low priority, although it may negatively impact quality of life.
No takes yet. Share an insight, caveat, or question.
Surendran et al. (2021) conducted a systematic review in Cardiac implantable electronic devices (n=696). Cardiac implantable electronic device implantation was evaluated on Upper extremity dysfunctions (pain and limitation of shoulder range of motion). Cardiac implantable electronic device implantation was associated with upper extremity dysfunctions, primarily pain and limited shoulder range of motion, in a systematic review of 696 participants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: